Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C

Journal of Medical Virology

Volumn 84, Issue 1, 2012, Pages 56-60

  Silva, Giovanni Faria ^a   Grotto, Rejane Maria Tommasini ^a   Verdichio Moraes, Camila Fernanda ^a   Corvino, Silvia Maria ^a   Ferrasi, Adriana Camargo ^a   de Arruda Silveira, Liciana Vaz ^a   De Moura Campos Pardini, Maria Inês ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Degree of fibrosis; Hepatitis C virus; Human platelet antigen

Indexed keywords

ANTIVIRUS AGENT; GENOMIC DNA; HUMAN PLATELET ANTIGEN 1; HUMAN PLATELET ANTIGEN 1A; HUMAN PLATELET ANTIGEN 1B; HUMAN PLATELET ANTIGEN 3; HUMAN PLATELET ANTIGEN 5; HUMAN PLATELET ANTIGEN 5B; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING SYSTEM;

ADULT; ANTIGENS, HUMAN PLATELET; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

HEPATITIS C VIRUS;

EID: 81355161127     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22191     Document Type: Article

References (37)

1. Almeida AJ, Campos-de-Magalhães M, Melo Marçal OP, Brandão-Mello CE, Okawa MY, de Oliveira RV, do Espírito-Santo MP, Yoshida CF, Lampe E. 2004. Hepatitis C virus-associated thrombocytopenia: A controlled prospective, virological study. Ann Hematol 83: 434-440.
2. Bataller R, Brenner DA. 2005. Liver fibrosis. J Clin Invest 115: 209-218.
3. Bissell DM, Roulot D, George J. 2001. Transforming growth factor β and the liver. Hepatology 34: 859-867.
4. Bussel J, Kaplan C. 1998. The fetal and neonatal consequences of maternal alloimmune thrombocytopenia (Review). Baillieres Clin Haematol 11: 3911-3918.
5. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P. 1996. Expression and function of integrins receptors for collagen and laminin in cultured human hepatic stellate cells. Gastroenterology 110: 1127-1136.
6. Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. 2001. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34: 809-816.
7. Friedman SL. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250.
8. Friedman SL. 2003. Liver fibrosis-From bench to bedside. J Hepatol 38: S38-S53.
9. Gao R, Brigstock DR. 2004. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279: 8848-8855.
10. Ginès P, Cárdenas A, Arroyo V, Rodés J. 2004. Management of cirrhosis and ascites. N Engl J Med 350: 1646-1654.
11. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC. 1995. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1: 932-937.
12. Hamaia S, Li C, Allain JP. 2001. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 98: 2293-2300.
13. Hernández F, Blanquer A, Linares M, López A, Tarín F, Cerveró A. 1998. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 99: 217-220.
14. Jiménez Sáenz M, Carmona Soria I, Caunedo Alvarez A, González Vílchez J. 2000. Absence of antiviral activity of high-dose subcutaneous beta-interferon in patients with chronic infection by genotype 1 virus C hepatitis. Med Clin (Barc) 114: 717.
15. Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller-Eckhardt C. 1994. Localization of the Br polymorphism on a 144bp exon of the GPIa gene and its application for platelet DNA typing. Tromb Haemost 71: 651-654.
16. Klüter H, Fehlau K, Panzer S, Kirchner H, Bein G. 1996. Rapid typing for human platelet antigen systems-1, -2, -3 and -5 by PCR amplification with sequence-specific primers. Vox Sang 71: 121-125.
17. Kunicki TJ, Newman PJ. 1992. The molecular immunology of human platelet proteins. Blood 80: 1386-1404.
18. Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomaki R, De Haas M, Aster R, Shibata Y, Smith J, Kiefel V, Santoso S. 2003. Nomenclature of human platelet antigens. Vox Sang 85: 240-245.
19. Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D. 2003. Loss of integrin alpha(v)beta6-mediated TGFbeta activation causes Mmp12-dependent emphysema. Nature 422: 169-173.
20. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. 1999. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328.
21. Nejjari M, Couvelard A, Mosnier JF, Moreau A, Feldmann G, Degott C, Marcellin P, Scoazec JY. 2001. Integrin up-regulation in chronic liver disease: Relationship with inflammation and fibrosis in chronic hepatitis C. J Pathol 195: 473-481.
22. Pinzani M, Marra F. 2001. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 21: 397-416.
23. Popov Y, Patsenker E, Stickel F, Zaks J, Bhaskar KR, Niedobitek G, Kolb A, Friess H, Schuppan D. 2008. Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol 48: 453-464.
24. Poujol-Robert A, Boëlle PY, Wendum D, Poupon R, Robert A. 2006. Association between ABO blood group and fibrosis severity in chronic hepatitis C infection. Dig Dis Sci 51: 1633-1636.
25. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR. 2000. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31: 828-833.
26. Poynard T, Bedossa P, Opolon P. 1997. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349: 825-832.
27. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. 2001. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34: 730-739.
28. Pugliese A, Gennero L, Cutufia M, Enrietto M, Morra E, Pescarmona P, Ponzetto A. 2004. HCV infective virions can be carried by human platelets. Cell Biochem Funct 22: 353-358.
29. Racine-Samson L, Rockey DC, Bissell DM. 1997. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem 272: 30911-30917.
30. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. 2001. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21: 351-372.
31. Seef LB. 2002. Natural history of chronic hepatitis C. Hepatology 36: S35-S46.
32. Takada Y, Ye X, Simon S. 2007. Protein family review: The integrins. Genome Biol 8: 215-219.
33. Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, Fox R, McCruden EA, MacSween RN, Mills PR. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002. 50: 248-252.
34. Toralles-Pereira C, Pardini MIMC, Deffune E, Machado PEA. 2005. The first report of the allele HPA-4b in a Brazilian. Int J Immunogenet 32: 165-166.
35. Verdichio-Moraes CF, Toralles-Pereira C, Grotto RMT, Silva GF, Pardini MIM. 2009. Allelic frequencies of HPA-1 to 5 human platelet antigens in patients infected with hepatitis C virus. J Med Virol 81: 757-759.
36. Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, Apple R, Cheng S, Thomas H, Thursz M. 2003. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut 52: 1206-1210.
37. Yee LJ. 2004. Host genetic determinants in hepatitis C virus infection. Genes Immun 5: 237-245.